Hikma Pharmaceuticals Plc Company Profile (LON:HIK)

Analyst Ratings

Consensus Ratings for Hikma Pharmaceuticals Plc (LON:HIK) (?)
Ratings Breakdown: 2 Hold Rating(s), 10 Buy Rating(s)
Consensus Rating:Buy (Score: 2.83)
Consensus Price Target: GBX 2,586.90

Analysts' Ratings History for Hikma Pharmaceuticals Plc (LON:HIK)
Show:
DateFirmActionRatingPrice TargetActions
7/22/2016Numis Securities LtdInitiated CoverageAddGBX 2,830View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/21/2016Morgan StanleyInitiated CoverageEqual weightGBX 2,700View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/5/2016Jefferies GroupBoost Price TargetBuyGBX 2,380 -> GBX 2,800View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/24/2016Stifel NicolausReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/1/2016JPMorgan Chase & Co.Reiterated RatingOverweightGBX 2,300View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/11/2016Barclays PLCBoost Price TargetOverweightGBX 2,760 -> GBX 2,800View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/11/2016Citigroup Inc.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/29/2016HSBCReiterated RatingBuyGBX 2,525View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/16/2016Panmure GordonUpgradeBuyGBX 2,120View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/10/2016AlphaValueReiterated RatingBuyGBX 2,554View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/15/2015Goldman Sachs Group Inc.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/2/2015Shore CapitalUpgradeBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2015Beaufort SecuritiesReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/24/2014 forward)

Earnings

Earnings History for Hikma Pharmaceuticals Plc (LON:HIK)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Hikma Pharmaceuticals Plc (LON:HIK)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Hikma Pharmaceuticals Plc (LON:HIK)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
3/11/2015GBX 0.210.64%4/16/20154/16/20155/21/2015Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Hikma Pharmaceuticals Plc (LON:HIK)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/24/2016Darwazah,MazenInsiderBuy150,000GBX 2,200£3,300,000Tweet This Trade  Share This Trade on StockTwits
6/17/2016Al-Husry,AliInsiderBuy70,000GBX 22£15,400Tweet This Trade  Share This Trade on StockTwits
5/9/2016Darwazah,SaidInsiderBuy17,440GBX 2,228£388,563.20Tweet This Trade  Share This Trade on StockTwits
4/26/2016Darwazah,SaidInsiderBuy10,000GBX 2,260£226,000Tweet This Trade  Share This Trade on StockTwits
4/25/2016Darwazah,SaidInsiderBuy10,000GBX 2,324£232,400Tweet This Trade  Share This Trade on StockTwits
4/22/2016Darwazah,SaidInsiderBuy30,000GBX 2,325£697,500Tweet This Trade  Share This Trade on StockTwits
4/20/2016Darwazah,SaidInsiderBuy30,000GBX 2,271£681,300Tweet This Trade  Share This Trade on StockTwits
4/19/2016Darwazah,SaidInsiderBuy30,000GBX 2,266£679,800Tweet This Trade  Share This Trade on StockTwits
4/11/2016J. Castellani,JohnInsiderBuy2,500GBX 2,103£52,575Tweet This Trade  Share This Trade on StockTwits
4/7/2016Darwazah,MazenInsiderBuy60,000GBX 2,118£1,270,800Tweet This Trade  Share This Trade on StockTwits
4/5/2016Darwazah,SaidInsiderBuy30,000GBX 2,055£616,500Tweet This Trade  Share This Trade on StockTwits
3/31/2016Darwazah,SaidInsiderBuy30,000GBX 1,972£591,600Tweet This Trade  Share This Trade on StockTwits
3/24/2016Butler,PatInsiderBuy2,500GBX 1,920£48,000Tweet This Trade  Share This Trade on StockTwits
3/21/2016Pickering ,RobertInsiderBuy2,500GBX 1,856£46,400Tweet This Trade  Share This Trade on StockTwits
8/27/2015Kirby,PamelaInsiderBuy3,317GBX 2,264£75,096.88Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Hikma Pharmaceuticals Plc (LON:HIK)
DateHeadline
07/23/16 04:11 PMUK stocks higher at close of trade; Investing.com United Kingdom 100 up 0.47% - Investing.com
07/23/16 04:11 PMNumis Securities Gives Hikma Pharmaceuticals PLC Price Target With Potential 9.86% Upside - FTSE News
07/22/16 04:22 PMHikma Pharmaceuticals : Morgan Stanley Begins Coverage on Hikma Pharmaceuticals Plc (HIK)
07/22/16 03:10 PMHikma Pharmaceuticals Plc : Undervalued relative to peers, but don’t ignore the other factors -
07/21/16 04:35 PMHikma Reports Court Approval To Continue Marketing Colchicine Products In U.S.
07/21/16 04:35 PMHikma Pharmaceuticals : Regulatory Approval Of Hikma's Colchicine Capsule Upheld By US Court
07/21/16 04:35 PMA report released today by Morgan Stanley about (LON:HIK) Hikma Pharmaceuticals PLC raises the target price to 2,700GBX
07/21/16 10:27 AMHikma reports Court approval to continue marketing colchicine products in U.S. - RTT News
07/21/16 10:27 AMBRIEF-Hikma says US Court of Appeals upholds regulatory approval of colchicine - Reuters
07/20/16 08:45 PMWest-Ward Pharmaceuticals launches capecitabine tablets
07/20/16 08:45 PMHikma Launches Generic Xeloda Tablets 150 Mg And 500 Mg In U.S.
07/20/16 08:45 PMTOP NEWS: Hikma Pharmaceuticals Launches Xeloda Tablets In US
07/20/16 08:45 PMHikma launches generic Xeloda tablets in U.S.
07/20/16 07:23 AMHikma launches generic Xeloda tablets in US - MarketWatch
07/20/16 07:23 AMBRIEF-Hikma Pharma announces US launch of two generic tablets - Reuters
07/20/16 04:16 AMFTSE rallies though miners lag - [Reuters] - By Kit Rees LONDON (Reuters) - UK shares advanced on Wednesday, supported by recent currency weakness and gains in healthcare stocks, though miners fell after updates from Anglo American (AAL.L) and BHP ...
07/15/16 07:37 AMWere Analysts Bullish Hikma Pharmaceuticals Plc (LON:HIK) This Week? - Consumer Eagle
07/15/16 01:10 AMIs it too late to buy rapid risers ARM Holdings plc, WPP plc ord 10p and Hikma Pharmaceuticals plc? -
07/13/16 07:21 AMUK shares higher at close of trade; Investing.com United Kingdom 100 up 0.04% - Investing.com UK
07/13/16 07:21 AMHikma Pharmaceuticals Plc Stock Is Crashing Now - Consumer Eagle
07/07/16 07:19 AMHikma Pharmaceuticals PLC (LON:HIK) Issued With 'Buy' Rating At Jefferies & Co - FTSE News
07/06/16 04:38 PMJefferies International Gives Hikma Pharmaceuticals PLC Price Target With Potential 12.49% Upside - FTSE News
07/05/16 04:19 PMJefferies covered (LON:HIK) Hikma Pharmaceuticals, stepping up its price target to GBX2,800 earlier today
07/05/16 04:45 AM3 Brexit-resistant shares -
07/01/16 04:27 PMLyon manufacturing facility returns to the Vectura Group - PharmiWeb.com (press release)
06/30/16 04:42 PMHikma Pharmaceuticals (LON:HIK) New Price Targets - FTSE News
06/29/16 07:21 PMHikma Pharmaceuticals to participate in The World Economic Forum’s Industry Strategy Meeting - [at noodls] - Hikma Pharmaceuticals to participate in The World Economic Forum's Industry Strategy Meeting Amman, June 2016 - Hikma Pharmaceuticals PLC (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), (rated Ba1 Moody's ...
06/29/16 04:24 PMHikma Pharmaceuticals : to participate in The World Economic Forum's Industry Strategy Meeting
06/29/16 03:28 AMEuropean healthcare first sector to recover Brexit losses - [Reuters] - The rush to large-cap, high quality, dividend-paying pharmaceutical stocks in the aftermath of Brexit has helped Europe's healthcare index erase all its losses since last week's vote. The healthcare index, up 1.4 percent on Wednesday, is the only regional sector index to trade above last Thursday's close.
06/27/16 08:49 AMHikma Pharmaceuticals : acquires six injectable products in Europe
06/27/16 03:46 AMHikma Pharmaceuticals Plc breached its 50 day moving average in a Bullish Manner : HIK-GB : June 27, 2016 -
06/26/16 03:53 PMEarnings are set to sink at Burberry Group plc, Hikma Pharmaceuticals plc and J Sainsbury plc! Should you buy? - Motley Fool UK
06/24/16 10:54 AMHikma Pharmaceuticals PLC (LON:HIK) stock price target held steady to GBX0 as recorded today by Stifel
06/24/16 03:10 AMHikma acquires six injectable products in Europe - [at noodls] - London, 24 June 2016 - Hikma Pharmaceuticals PLC (Hikma) (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), (rated Ba1 Moody's / BB+ S&P, both stable), the fast growing multinational pharmaceutical group, announces ...
06/23/16 07:21 AMRoyal Jordanian : Said Darwazeh elected RJ Chairman of the Board of Directors; Suleiman Obeidat appointed a board member
06/23/16 07:21 AMSaid Darwazeh elected RJ chairman of the board of directors
06/22/16 04:33 PMRJ elects Darwazeh as chairman of Board of Directors
06/20/16 04:13 PMShould you buy or sell Majestic Wines plc, Enquest plc and Hikma Pharmaceuticals plc after today's news? - Yahoo Finance UK
06/20/16 02:34 PMHikma Pharmaceuticals Plc – Value Analysis (LONDON:HIK) : June 20, 2016 -
06/18/16 08:51 AMNewly released market study: Schistosomiasis Global Clinical Trials Review, H1, 2016
06/15/16 04:29 PMUK stocks higher at close of trade; Investing.com United Kingdom 100 up 0.78% - Investing.com
06/14/16 03:50 AMHikma Pharmaceuticals Plc breached its 50 day moving average in a Bearish Manner : HIK-GB : June 14, 2016 -
06/13/16 11:49 AMHikma receives FDA approval for Letrozole Tablets - [at noodls] - London, 13 June 2016 - Hikma Pharmaceuticals PLC (Hikma) (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), (rated Ba1 Moody's / BB+ S&P, both stable), the fast growing multinational pharmaceutical group, announces ...
06/09/16 04:34 PMHikma seeks dismissal of Takeda's bid to block gout drug sales
06/07/16 03:38 AMHikma Pharmaceuticals Egypt launches Hikma Specialized division to bring advanced affordable medicines to patients in need - [at noodls] - Cairo, June, 2016 - Hikma Pharmaceuticals Egypt announced early this month, the launch of its new business unit 'Hikma Specialized Egypt' as part of their strategic vision focusing on high need areas and ...
06/06/16 04:20 PMHikma Pharmaceuticals : receives FDA approval for Ketamine Hydrochloride Injection
06/04/16 04:28 PMHikma Pharmaceuticals Plc (HIK) Stock Rating Reaffirmed by JPMorgan Chase & Co. - Let Me Know About This
06/03/16 07:04 AMJP Morgan Cazenove Gives Hikma Pharmaceuticals PLC Price Target With Potential 0.09% Upside - FTSE News - FTSE NewsJP Morgan Cazenove Gives Hikma Pharmaceuticals PLC Price Target With Potential 0.09% UpsideFTSE NewsJP Morgan Cazenove gave the share price of Hikma Pharmaceuticals PLC a price target of 2300 meaning the broker expects a potential upside of 0.09% from Hikma Pharmaceuticals PLC's current market price of 2298. Hikma Pharmaceuticals PLC has ...Hikma Pharmaceuticals (LON:HIK) Analyst Target ChangesShare Trading Newsall 3 news articles »
06/03/16 06:53 AMIn fight for GSK's Advair, generic firms step carefully on price - [Reuters] - Generic drugmakers, hoping for rich pickings from the launch of copies of GlaxoSmithKline's best-selling Advair inhaler in the United States next year, say they can win business without a race to the bottom on price. "Nobody wants to kill the market," said Rajiv Malik, president of Mylan, which will have the first commercial Advair copy, assuming U.S. regulators approve its substitutable generic device by a target date of March 28, 2017.
06/02/16 07:10 AMHikma Pharmaceuticals hits Footsie as oil and mining dip - Proactive Investors UK - Proactive Investors UKHikma Pharmaceuticals hits Footsie as oil and mining dipProactive Investors UKDrug company Hikma Pharmaceuticals PLC (LON:HIK) ascended to the FTSE 100 Index as the decline of oil and mining in London's top flight continued. Hikma is set to enter the FTSE 100 in the latest quarterly review of the index at the expense of ...JP Morgan Cazenove Gives Hikma Pharmaceuticals PLC Price Target With Potential 0.09% UpsideFTSE NewsHikma Pharmaceuticals bounces back into FTSE 100EveryInvestorFTSE 100 ETFs in focus as UK index completes quarterly reviewETF Strategyall 4 news articles »

Social

About Hikma Pharmaceuticals Plc

Hikma Pharmaceuticals Plc logoHikma Pharmaceuticals PLC is a pharmaceutical company engaged the development, manufacture and marketing of a range of generic and in-licensed pharmaceutical products in solid, semi-solid, liquid and injectable final dosage forms. The Company is focused on therapeutic areas, such as oncology, diabetes and cardiovascular and central nervous system (CNS). The Company's operations are conducted through three business segments: Branded, Injectables and Generics. Its Branded business manufactures and markets generic and in-licensed originator products across the Middle East and North Africa (MENA) region. Its Injectables business manufactures and markets branded and non-branded generic injectable products in the United States, Europe and MENA. Its Generics business manufactures non-branded oral generic products for sale in the United States market. It operates primarily in the MENA region, the United States and Europe.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: LON
  • Symbol: HIK
  • CUSIP:
Key Metrics:
  • Previous Close: $33.44
  • 50 Day Moving Average: $2387.51
  • 200 Day Moving Average: $2142.69
  • P/E Ratio: 20.65
  • P/E Growth: 1.33
  • Market Cap: $5.16B
  • Current Year EPS Consensus Estimate: $1.17 EPS
  • Next Year EPS Consensus Estimate: $N/A EPS
Additional Links: